Back to Studies

P1012 / PK Study of Once Versus Twice Dosing with Combivir

Phase 1 Pharmacokinetic Study of Once Versus Twice Daily Zidovudine And Lamivudine

Study Status

Concluded

DAIDS Number

10266

IND Number

Non-IND

Primary Protocol Team Members

Patricia Flynn Study Chair

Jose Rodriguez Study Vice-Chair

Summary

Phase 1 Pharmacokinetic Study of Once- Versus Twice-Daily Zidovudine and Lamivudine

Loading study documents...

Loading study sites...

Loading study protocol team...

Loading study press...

Loading study publications/presentations...